IShares Global Valuation
| IXJ Etf | USD 91.22 0.81 0.90% |
At this time, the entity appears to be fairly valued. iShares Global Healthcare retains a regular Real Value of $91.59 per share. The prevalent price of the entity is $91.22. Our model calculates the value of iShares Global Healthcare from evaluating the entity fundamentals such as Return On Asset of 0.88, shares outstanding of 35.85 M, and Return On Equity of 23.19 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that IShares Global's price fluctuation is very steady at this time. Calculation of the real value of iShares Global Healthcare is based on 3 months time horizon. Increasing IShares Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
IShares Global's intrinsic value may or may not be the same as its current market price of 91.22, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 91.22 | Real 91.59 | Hype 90.54 | Naive 89.83 |
The intrinsic value of IShares Global's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence IShares Global's stock price.
Estimating the potential upside or downside of iShares Global Healthcare helps investors to forecast how IShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IShares Global more accurately as focusing exclusively on IShares Global's fundamentals will not take into account other important factors: IShares Global Total Value Analysis
iShares Global Healthcare is currently anticipated to have company total value of 3.06 B with market capitalization of 3.05 B, debt of 1.62 M, and cash on hands of 9.76 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the IShares Global fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.06 B | 3.05 B | 1.62 M | 9.76 M |
IShares Global Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IShares Global has an asset utilization ratio of 1.26 percent. This denotes that the ETF is making $0.0126 for each dollar of assets. An increasing asset utilization means that iShares Global Healthcare is more efficient with each dollar of assets it utilizes for everyday operations.IShares Global Ownership Allocation
iShares Global Healthcare has a total of 35.85 Million outstanding shares. The majority of iShares Global Healthcare outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IShares Global to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in iShares Global Healthcare. Please pay attention to any change in the institutional holdings of iShares Global Healthcare as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the entity is less than the current market value, you may not be able to make money on it.IShares Global Profitability Analysis
The company reported the last year's revenue of 43.28 M. Total Income to common stockholders was 539.56 M with profit before taxes, overhead, and interest of 43.28 M.About IShares Global Valuation
An absolute valuation paradigm, as applied to IShares Etf, attempts to find the value of iShares Global Healthcare based on its fundamental and basic technical indicators. By analyzing IShares Global's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of IShares Global's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of IShares Global. We calculate exposure to IShares Global's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IShares Global's related companies.The fund generally invests at least 80 percent of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Global Healthcare is traded on NYSEARCA Exchange in the United States.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Global Healthcare. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
The market value of iShares Global Healthcare is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Global's value that differs from its market value or its book value, called intrinsic value, which is IShares Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Global's market value can be influenced by many factors that don't directly affect IShares Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.